Exam 4 Week 2 Flashcards
Cortisol physiology
10% free in blood, 90% bound (CBG, albumin)
Receptor is cytosolic (HSP-90)
Delayed onset, longer response
Metabolic effects of cortisol
Counter-regulatory hormone:
- Liver gluconeogenesis
- Fatty acid oxidation (centripedal obesity)
- Protein breakdown (increased AA)
- Permissive epi: increased glycogenolysis and HSL activity)
Circulatory effects of cortisol
- Increased RBC production (polycythemia, anemia)
2. Permissive epi: enhance ß-adrenergic activity (CV tone)
Bone effects of cortisol
- Increased cortisol: decreased fibroblast proliferation (decreased collagen synthesis)= thin skin, striae
- Cortisol = vit D antagonist
Anti-inflammatory and immunosuppression effects of cortisol
Inhibits phospholipase A2 (PLC?) to prohibit arachidonic acid formation (affects COX and LOX downstream)
Decreased T cell activation and proliferation (decreased IL-2)
Decreases WBC, but increases neutrophils
Inhibits release of histamine
ACTH derived from
POMC gene
Also includes MSH genes (including on ACTH)
Hypocortisolemia and labs
1˚: Addison’s (destruction)
Cort down, ACTH up, aldo down
2˚: Pituitary or hypothalamus
Cort down, ACTH down, nml aldo (RAAS)
Stress response overview
Two physiologic areas:
- Locus ceruleus: increased NE, arousal
- Hypothalamus: CRH, ACTH, cortisol
- Hypothalamus: Splanchnic nerve, epi
Effects of epi
Increase of blood glucose Increase FFA (via HSL) Decreased insulin (alpha-2 stimulation)
Layers of adrenal gland and production
Glomerulosa: mineralcorticoids (salt)
Fasciculata: glucocorticoids (sugar)
Reticularis: weak androgens, DHEA/androstenedione (sex)
Medulla: epi (and some NE)
Adrenal medulla origin and cell type
Neural crest origin
Chromaffin cells secrete epi and NE
Dopamine/NE pathway
Transporter in/out of vesicle
Enzymes
Tyrosine - L DOPA - Dopamine - NE - Epi
VMAT-1
Tyrosine hydroxylase, Decarboxylase, Dopamine ß-hydroxylase, PNMT
Aldosterone release, effects
Stimulated by ATII and ACTH
Principal cell: K+ out, Na+ in
alpha intercalated cell: H+ out
Hyperaldosteronism
HTN, hypokalemia, metabolic alkalosis (basic pH)
Primary: often bilateral adrenal hypoplasia (low renin)
Secondary: chronic activation of RAAS (high renin)
Ex: CAD, HF, cirrhosis
Types of congenital adrenal hyperplasia
21-OH deficiency: low cort, low aldo, high sex
11-OH deficiency: low cort, nml aldo, high sex
17-OH deficiency: low cort, low sex, high aldo
Pheochromocytoma triad presentation
Intermittent:
Headache
Palpitations
Diaphoresis
Pheo: origin and associated syndromes
Adults Adrenal medulla Chromaffin cells (from neural crest) NF-1, VHL, MEN1/2 (RET) SDHB and SDHD (B=bad, D=dad)
Rule of 10’s for pheo
Malignant Bilateral Extra-adrenal (bladder) Calcify Kids
Pheo dx, imaging, and tx
Urine/plasma metanephrines/catecholamines
Clonidine suppression tet
CT, MRI, I-123 (localize)
Surgical resection after irreversible a-blockers and ß-blockers (phenoxybenzamine)
Genetics follow up!
Paraganglioma
Neuroendocrine derived tumor
Chromaffin negative
Sympathetic
MEN gene associations
MEN2A: Pheo, thyroid carcinoma, hyperparathyroidism
MEN2B: Pheo, thyroid carcinoma, mucosal neuro tumor
2B - often marfanoid habitus
DDx for pheo
Exogenous drug
Hyperthyroidism
Carcinoid tumor
GAD with HTN
Primary hyperaldosteronism (Conn’s)
High aldo, low renin
1/3= adenoma
2/3= bilateral adrenal hypertrophy
rare= carcinoid tumor
Mechanism of glucocorticoid-remediable aldosteronism and treatment
Autosomal dominant
Crossing over between genes for 11-OH and aldose synthase leading to ACTH activated (and overactivated) aldose synthase
= Hyperaldosteronism
Tx: GC’s to suppress ACTH
2 main clinical features of hyperaldosteronism
Difficult to control HTN
Hypokalemia
Aldosteronism lab eval
Correct K and measure plasma renin and aldo
Aldo/renin >20 = primary hyperaldo
Saline suppression test (aldo>10)
CT to localize (>35 with >1cm mass also AVS)
No mass or <1cm = AVS
Bilateral enlargement = genetic testing GRA
Adrenal insufficiency causes
Primary (high ACTH, pigmentation):
Autoimmune, infections (TB, HIV), hemorrhagic, CA, ketoconazole (block cortisol receptor)
Secondary (low ACTH, nml pigmentation and MC):
Exogenous GC drug, hypopituitarism, hypothalmic dysfxn
Lab findings in primary vs. secondary adrenal insufficency
Primary: ACTH high, MSH high, hyperkalemia
Secondary: ACTH low, no hyperkalemia
Both: Hypoglycemia, eosinophilia
Waterhouse-Friderichsen syndrome
Acute primary adrenal insufficency due to hemorrhage
Associated with sepsis in N. men, DIC, and endotoxic shock
Neuroblastoma
Most common adrenal medullary tumor in children
Crosses midline, occurs anywhere in sympathetic chain (from neural crest cells)
Licorice induced hyperaldosteronsim
Licorice inhibits breakdown of cortisol in kideny
Cortisol has greater affinity for MC receptor
Build up of cortisol activates MC receptor
Hyperaldo treatment
Unilateral: surgery
Bilateral: MC antagonist (K+ sparing)
Adrenal incidentalomas - benign
Majority are non-fxnal adenoma HU<10 on noncon CT = benign nodule Dropout on MRI = benign nodule <4cm, homogenous, smooth Rapid washout (>50%) Observation and follow up
Adrenal incidentalomas - malignant
Central necrosis HU>10 on part without necrosis HU>30 likely adrenocortical carcinoma HU>20 likely pheo HU>10 likely mets Low washout Surgery - removal